CCCC: c4therapeutics.com Net earnings per share for the last 12 months

Symbol and logo of brand C4 Therapeutics (CCCC)

The stability of global component supplies from Asia creates a foundation for the development of C4 Therapeutics, Inc. (CCCC). The rolling trailing twelve-month earnings per share confirms this trend, demonstrating a metric value of -0.72. Growth is supported by the validation of protein degradation methods, while success is driven by an innovative R&D pipeline in precision oncology and partnerships with pharmaceutical behemoths.

CCCC (C4 Therapeutics, Inc.) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/16/2026

Analytical breakdowns for C4 Therapeutics, Inc.

- share price and expert price forecast:
Basic company analysis:C4 Therapeutics, Inc. - CCCC
Manufactured products of C4 Therapeutics Inc

Net income per share (TTM) measures the final business profitability per share of capital over a rolling year, allowing for the mitigation of quarterly volatility. The current value of -0.72 and the rolling earnings per share trend reflect the balance between R&D expenditures for targeted drugs and the inflow of funds from strategic partnerships with pharmaceutical behemoths for C4 Therapeutics, Inc. (CCCC).

Who C4 Therapeutics, Inc. competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (Exelixis Corp)|NUVL (Nuvalent) - Net earnings per share for the last 12 months|KYMR: Earnings per share for the last four quarters|IDYA (IDEAYA Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) enliventherapeutics.com|Earnings per share for the last twelve months ORIC Pharmaceuticals, Inc. (ORIC)|RLAY (Relay Therapeutics, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NRIX (Nurix Therapeutics Inc)|Net earnings per share for the trailing year Tyra Bio|Verastem Oncology - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Monte Rosa Therapeutics, Inc.|CGEM (Cullinan Therapeutics) - Net earnings per share for the last 12 months|IMRX: Earnings per share for the last four quarters|BDTX (blackdiamondtherapeutics.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Repare Rx RPTX|Net earnings per share (EPS TTM) PMVP|Karyopharm - Earnings per share for the last 12 months|Propanc Biopharma Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGMS|AADI: Net earnings per share for the last 12 months|aileronrx.com - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics Inc. - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics, Inc) - Net earnings per share (EPS TTM)